Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular vesicles (EVs) are lipid-enclosed particles actively released by cells, functioning as key mediators of intercellular communication. They carry a diverse cargo of proteins, nucleic acids (including mRNA and miRNA), and lipids that can modulate the behavior of recipient cells. EVs influence cell migration and differentiation by affecting directional sensing, cell adhesion, ECM degradation, and lineage-specific differentiation pathways. Targeting EV-mediated pathways offers potential strategies for modulating pathological processes and enhancing regenerative medicine approaches.
Modulation of cell signaling pathways via cargo delivery (proteins, mRNAs, miRNAs, lipids) and subsequent alteration of gene expression programs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular Vesicles (EVs).